Trials / Completed
CompletedNCT02978456
Quantitative Coronary Angiography Versus Intravascular Ultrasound GUIDancE for Drug-Eluting Stent Implantation
Quantitative Coronary Angiography Versus Intravascular Ultrasound GUIDancE for Drug-Eluting Stent Implantation: GUIDE-DES Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,528 (actual)
- Sponsor
- CHEOL WHAN LEE, M.D., Ph.D · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare clinical outcomes between quantitative coronary angiography -guided and Intravascular ultrasound -guided strategy in patients with significant coronary artery disease undergoing sirolimus-eluting Orsiro/Orsiro mission stent implantation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | quantitative coronary angiography guided coronary intervention with sirolimus-eluting Orsiro/Orsiro mission stent | In the quantitative coronary angiography-guided group, sirolimus-eluting Orsiro/Orsiro mission stent size and length is chosen to cover the entire length of the culprit lesions according to quantitative coronary angiography measurements. Selection of the sirolimus-eluting Orsiro/Orsiro mission stent size should be guided by both quantitative coronary angiography measurement and visual estimate, and is recommended to be based on distal reference vessel diameter by quantitative coronary angiography (distal reference vessel diameter by quantitative coronary angiography plus \~10% of distal reference vessel diameter). |
| DEVICE | intravascular ultrasound guided coronary intervention with sirolimus-eluting Orsiro/Orsiro mission stent | In the intravascular ultrasound -guided group, sirolimus-eluting Orsiro/Orsiro mission stent size and length is selected by intravascular ultrasound measurements. |
Timeline
- Start date
- 2017-02-23
- Primary completion
- 2022-08-23
- Completion
- 2022-08-23
- First posted
- 2016-12-01
- Last updated
- 2025-01-01
Locations
6 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02978456. Inclusion in this directory is not an endorsement.